Latest information on COVID-19
Support teaching, research, and patient care.
Dr. Behr graduated from University of Nevada-Reno with honors and earned his Ph.D. with emphasis in Reproductive Physiology in 1991, board certified as High Complexity Laboratory Director in 1994, and board certified as Embryology Laboratory Director in 2003.Dr. Behr is a nationally and internationally renowned clinical and scientific leader in the research and advances of human reproduction. As a world-renown scientist and lecturer, he is highly sought after to chair scientific programs and conferences, was the first non M.D. President of the Pacific Coast Reproductive Society, and has been appointed as program chair of several professional meetings. He is in the forefront of clinical and scientific advances in reproduction, nationally and internationally as an entrepreneur and has founded several fertility related businesses. Dr. Behr developed a culture medium for embryo culture to the blastocyst stage, which improved pregnancy rates, implantation rates and reduced the risks of multiple gestation in IVF. Dr. Behr has been widely recognized for his research. He has published over 90 peer-reviewed publications, and has authored over 170 abstracts and 14 book chapters.Dr. Behr enjoys racing cars, golfing, barbequing, and spending time with his family.
Development of improved embryo culture conditions in vitro. Blastocyst cultures. Embryo metabolism in vitro. Embryo maternal dialogue. Clinical application and integration of extended embryo culture systems. Monozygotic twinning. Prevention of multiple pregnancy. Sperm motility enhancers. Fluorescent and non-fluorescent markers of sperm morphology and viablility.Oocyte cryopreservation. Fertility preservation. Improving IVF outcome.
Day of Embryo Transfer for Patients Undergoing In Vitro Fertilization
We are examining whether pregnancy rates differ based on day of embryo transfer in patients
who replace all available embryos after an In vitro Fertilization (IVF) cycle. Patients must
be undergoing IVF treatment at Stanford University and patients will not receive compensation
for their participation (no medical costs covered or patient payment for participation).
Stanford is currently not accepting patients for this trial.
For more information, please contact Lora Shahine, 6504987911.
View full details